Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy-Reference-Cited by-同舟云学术

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy

Published:2017-05-11 Issue:5 Volume:18 Page:1035
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Coco Simona,Alama Angela^ORCID,Vanni Irene,Fontana Vincenzo,Genova Carlo,Dal Bello Maria,Truini Anna,Rijavec Erika,Biello Federica,Sini Claudio,Burrafato Giovanni,Maggioni Claudia,Barletta Giulia,Grossi Francesco

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/5/1035/pdf

Reference47 articles.

1. Cancer statistics, 2017

2. Cancer Statistics Review 1975–2002;Ries,2005

3. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours;Goldstraw;J. Thorac. Oncol.,2007

4. A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors;Critical Reviews in Oncology/Hematology;2024-11

2. Chemotherapy related changes in cfDNA levels in squamous non-small cell lung cancer: correlation with symptom scores and radiological responses;Exploration of Targeted Anti-tumor Therapy;2024-05-28

3. The detection of circulating tumor cells indicates poor therapeutic efficacy and prognosis in patients with nonsmall cell lung cancer: A systematic review and meta‐analysis;Journal of Evidence-Based Medicine;2024-04-10

4. Establishing and Validating a novel Prognostic Model in the Initial Diagnosis of Non-small Cell Lung Cancer with Bone Metastases;Journal of Cancer;2024

5. Evolution of Biomarkers and Treatment Outcomes of Immunotherapy in Lung Cancer;Current Tissue Microenvironment Reports;2023-09-15